Arora, MD, S.; Setnik, PhD, B.; Drass, MD, M.; Hudson, MD, J. D.; Clemmer, MS, R.; Meisner, PharmD, P.; Pixton, MS, G. C.; Goli, MD, V.; Sommerville, MD, K. W. A Multicenter, 12-Month, Open-Label, Single-Arm Safety Study of Oxycodone-hydrochloride/Naltrexone-Hydrochloride Extended-Release Capsules (ALO-02) in Patients With Moderate-to-Severe Chronic Noncancer Pain. J of Opioid Management 2014, 10, 423-436.